ISRCTN07238689
Completed
Not Applicable
A randomised double-blind trial to investigate the efficacy of intra-articular bupivacaine for pain relief following ankle arthroscopy
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 sites48 target enrollmentSeptember 12, 2003
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Signs and Symptoms: Pain
- Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •48 patients aged \=18 years old undergoing day case ankle arthroscopy who have given informed written consent.
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Double-blind, randomised trial to investigate the antihypertensive and metabolic effects of candesartan in insulin-resistant obese patients with a hypertension not adequately controlled by previous beta-blocker or calcium channel blockerEUCTR2006-001998-25-DETakeda Pharma GmbH
Active, not recruiting
Phase 1
Effect of testosterone in male patients on regular hemodialysisHypogonadal males undergoing hemodialysis (HD).Therapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2011-005439-20-SEDept of Renal medicine40
Not yet recruiting
Not Applicable
The effect of ultrasound-guided transversus abdominis plane block on post-operative pain in laparoscopic cholecystectomyDiseases of the digestive systemKCT0004835Soon Chun Hyang University Hospital Bucheon76
Active, not recruiting
Phase 1
Efficacy and safety of intravenous neridronic acid in CRPS-IComplex regional pain syndrome type I (CRPS-I)MedDRA version: 18.0Level: LLTClassification code 10064334Term: Complex regional pain syndrome Type ISystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2014-001915-37-DEGrünenthal GmbH225
Active, not recruiting
Phase 1
Efficacy and safety of intravenous neridronic acid in CRPS-IEUCTR2014-001915-37-GBGrünenthal GmbH225